About This Bill
Latest Action · June 7, 2024
Referred to the House Committee on Energy and Commerce.
Summary
Highlight any text to annotate
This resolution condemns the Food and Drug Administration's decision in January 2023 to remove in-person dispensing requirements for mifepristone.
Take Action
Your position
Add a comment
to comment on this bill.
Annotate the text
Highlight any passage on the Summary or Full Text tab to attach a note. Annotations appear on the Annotations tab.